Status:

COMPLETED

Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SSc

Lead Sponsor:

Pamukkale University

Conditions:

Systemic Sclerosis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Functionality in patients with SSc? Systemic Sclerosis (SSc) is a chronic connective tissue disease characterized by microvascular involvement, immunological dysfunction, extracellular matrix depositi...

Detailed Description

Material-Method 34 SSc patients who were followed up in Pamukkale University Rheumatology due to DU are going to be included in the study. SSc is diagnosed and based on the American College of Rheumat...

Eligibility Criteria

Inclusion

  • • SSc patients who have no comorbidity

Exclusion

  • gangrenous ulcers
  • calcinosis-free ulcers
  • traumatic ulcers
  • vasculitis
  • active osteomyelitis
  • hyperthyroidism
  • pregnancy
  • allergies to ozone therapy

Key Trial Info

Start Date :

April 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2022

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04826419

Start Date

April 1 2021

End Date

January 1 2022

Last Update

January 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pamukkale Unıversity

Denizli, Turkey (Türkiye), 20020

Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SSc | DecenTrialz